Infographic | November 18, 2024

Select The Right Bayesian Optimized Interval (BOIN) Design For Your Oncology Study

Source: Worldwide Clinical Trials
GettyImages- 1180547354 trial data

Produce effective, reliable results in Phase 1 oncology trials with Bayesian Optimized Interval (BOIN) designs. These designs enable you to determine the maximum tolerated dose (MTD) or the optimal biological dose (OBD) with ease. With a superior performance compared to rules-based designs, the codified BOIN design is preferred by trials that need an uncommon toxicity threshold, more than 3 dose escalation levels, and flexibility to cohort size and backfilling. Discover which BOIN design best suits your trial needs.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader